サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1417727

人口スクリーニング市場レポート：2030年までの動向、予測、競合分析

Population Screening Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

人口スクリーニング市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

人口スクリーニングの動向と予測

世界の人口スクリーニング市場は、2024年から2030年にかけてCAGR 5.5％で成長します。この市場の主な促進要因は、医師と患者の間で慢性疾患の有病率が高まっていることと、人口スクリーニングプログラム分野への投資が増加していることです。世界の人口スクリーニング市場の将来は、大衆市場とプレミアム市場における機会により有望視されています。

人口スクリーニング市場の洞察

Lucintelは、より多くの疾患の集団スクリーニングのための新しい検査キットの承認が増加しているため、ハードウェア機器が予測期間中最大のセグメントであり続けると予測しています。

この市場では、包括的な集団スクリーニングを実施する上での課題が増加しているため、大衆向けが引き続き大きなセグメントとなります。

北米は、同地域の政府によって実施される予防措置により、予測期間中最大の地域であり続けるでしょう。

よくある質問

Q1.市場の成長予測は？

A1.世界の人口スクリーニング市場は、2024年から2030年にかけてCAGR 5.5%で成長する見込みです。

Q2.市場の成長に影響を与える主な促進要因は？

A2.この市場の主な促進要因は、医師や患者の間で慢性疾患の有病率が高まっていることと、人口スクリーニングプログラム分野への投資が増加していることです。

Q3.市場の主要セグメントは？

A3.集団検診市場の将来性は、大衆市場とプレミアム市場における機会により有望視されています。

Q4.市場の主要企業は？

A4.人口スクリーニングの主要企業は以下の通り。

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Q5.今後、最大となる市場セグメントは？

A5.Lucintelは、より多くの疾患の集団スクリーニングのための新しい検査キットの承認が増加しているため、予測期間中、ハードウェア機器が最大のセグメントであり続けると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は？

A6.予測期間中、北米は政府による予防措置により最大地域であり続ける。

Q7.レポートのカスタマイズは可能？

A7.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の人口スクリーニング市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の人口スクリーニング市場動向（2018-2023）と予測（2024-2030）
  • 製品別の世界の人口スクリーニング市場
    • ハードウェア設備
    • 試験/研究
    • 分析/解釈
  • 男女別の世界の人口スクリーニング市場
    • 男性
    • 女性
  • タイプ別の世界の人口スクリーニング市場
    • 大衆市場
    • プレミアム
  • ビジネス別の世界の人口スクリーニング市場
    • 病院
    • 調査機関
    • 診断研究所

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の人口スクリーニング市場
  • 北米の人口スクリーニング市場
  • 欧州の人口スクリーニング市場
  • アジア太平洋の人口スクリーニング市場
  • その他地域の人口スクリーニング市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界の人口スクリーニング市場の成長機会
    • 性別ごとの世界の人口スクリーニング市場の成長機会
    • タイプ別の世界の人口スクリーニング市場の成長機会
    • ビジネス別の世界の人口スクリーニング市場の成長機会
    • 地域別の世界の人口スクリーニング市場の成長機会
  • 世界の人口スクリーニング市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の人口スクリーニング市場の能力拡大
    • 世界の人口スクリーニング市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics
目次

Population Screening Trends and Forecast

The future of the global population screening market looks promising with opportunities in the mass and premium markets. The global population screening market grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases among physicians and patients and rising investments in the field of population screening programs.

A more than 150-page report is developed to help in your business decisions.

Population Screening by Segment

The study includes a forecast for the global population screening by product, gender, type, business, and region.

Population Screening Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Hardware Equipment
  • Testing / Lab
  • Analytics / Interpretation

Population Screening Market by Gender [Shipment Analysis by Value from 2018 to 2030]:

  • Male
  • Female

Population Screening Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Mass
  • Premium

Population Screening Market by Business [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Research Institutes
  • Diagnostic Labs

Population Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Population Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies population screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the population screening companies profiled in this report include-

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Population Screening Market Insights

Lucintel forecasts that hardware equipment will remain the largest segment over the forecast period due to growing approval of novel test kits foe the population screening of more diseases.

Within this market, mass will remain the larger segment due to increasing challenges in conducting comprehensive population screening.

North America will remain the largest region over the forecast period due to precautionary actions implemented by government in the region.

Features of the Global Population Screening Market

Market Size Estimates: Population screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Population screening market size by various segments, such as by product, gender, type, business, and region in terms of value ($B).

Regional Analysis: Population screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, gender, types, businesses, and regions for the population screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the population screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for population screening market?

Answer: The global population screening market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the population screening market?

Answer: The major drivers for this market are growing prevalence of chronic diseases among physicians and patients and rising investments in the field of population screening programs.

Q3. What are the major segments for population screening market?

Answer: The future of the population screening market looks promising with opportunities in the mass and premium markets.

Q4. Who are the key population screening market companies?

Answer: Some of the key population screening companies are as follows.

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Q5. Which population screening market segment will be the largest in future?

Answer: Lucintel forecasts that hardware equipment will remain the largest segment over the forecast period due to growing approval of novel test kits foe the population screening of more diseases.

Q6. In population screening market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to precautionary actions implemented by government in the region.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the population screening market by product (hardware equipment, testing / lab, and analytics / interpretation), gender (male and female), type (mass and premium), business (hospitals, research institutes, and diagnostic labs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Population Screening Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Population Screening Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Population Screening Market by Product
    • 3.3.1: Hardware Equipment
    • 3.3.2: Testing / Lab
    • 3.3.3: Analytics / Interpretation
  • 3.4: Global Population Screening Market by Gender
    • 3.4.1: Male
    • 3.4.2: Female
  • 3.5: Global Population Screening Market by Type
    • 3.5.1: Mass
    • 3.5.2: Premium
  • 3.6: Global Population Screening Market by Business
    • 3.6.1: Hospitals
    • 3.6.2: Research Institutes
    • 3.6.3: Diagnostic Labs

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Population Screening Market by Region
  • 4.2: North American Population Screening Market
    • 4.2.2: North American Population Screening Market by Type: Mass and Premium
  • 4.3: European Population Screening Market
    • 4.3.1: European Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.3.2: European Population Screening Market by Type: Mass and Premium
  • 4.4: APAC Population Screening Market
    • 4.4.1: APAC Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.4.2: APAC Population Screening Market by Type: Mass and Premium
  • 4.5: ROW Population Screening Market
    • 4.5.1: ROW Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.5.2: ROW Population Screening Market by Type: Mass and Premium

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Population Screening Market by Product
    • 6.1.2: Growth Opportunities for the Global Population Screening Market by Gender
    • 6.1.3: Growth Opportunities for the Global Population Screening Market by Type
    • 6.1.4: Growth Opportunities for the Global Population Screening Market by Business
    • 6.1.5: Growth Opportunities for the Global Population Screening Market by Region
  • 6.2: Emerging Trends in the Global Population Screening Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Population Screening Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Population Screening Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Agilent Technologies
  • 7.2: Thermo Fisher Scientific
  • 7.3: QIAGEN
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Quest Diagnostics